Literature DB >> 7774936

The structural genes, MEP1A and MEP1B, for the alpha and beta subunits of the metalloendopeptidase meprin map to human chromosomes 6p and 18q, respectively.

J S Bond1, K Rojas, J Overhauser, H Y Zoghbi, W Jiang.   

Abstract

Meprins are cell membrane, oligomeric metalloendopeptidases composed of two distinct but evolutionarily related subunits, alpha and beta. The structural genes for the meprin subunits, Mep-1 alpha and Mep-1 beta, have been previously mapped to chromosomes 17 and 18, respectively, of the mouse genome. We now report the localization of MEP1A and MEP1B in the human genome. MEP1A mapped to the short arm of chromosome 6 by the use of radiation and somatic cell hybrids. More specifically, it is localized between the centromere and GSTA2 in 6p11-p12. MEP1B mapped to chromosome 18, by the use of somatic cell hybrids, in 18q12.2-q12.3, proximal to the TTR/PALB gene. As in the mouse genome, the two homologous human structural genes for alpha and beta (50% identical on the cDNA level) are unlinked. These new markers on human chromosomes 6 and 18 extend the region of known linkage homology with mouse chromosomes 17 and 18, respectively, and provide new molecular access to regions of the human genome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774936     DOI: 10.1016/0888-7543(95)80142-9

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  18 in total

1.  Human N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase (human meprin): genomic structure of the alpha and beta subunits.

Authors:  D Hahn; R Illisson; A Metspalu; E E Sterchi
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease.

Authors:  Sanjita Banerjee; Ge Jin; S Gaylen Bradley; Gail L Matters; Ryan D Gailey; Jacqueline M Crisman; Judith S Bond
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-11       Impact factor: 4.052

3.  A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis.

Authors:  D E Jenne; K Denzel; P Blätzinger; P Winter; B Obermaier; R P Linke; K Altland
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Meprin beta metalloprotease gene polymorphisms associated with diabetic nephropathy in the Pima Indians.

Authors:  Alexander R Red Eagle; Robert L Hanson; Weiping Jiang; Xiaoli Han; Gail L Matters; Giuseppina Imperatore; William C Knowler; Judith S Bond
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

5.  MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease.

Authors:  S Banerjee; B Oneda; L M Yap; D P Jewell; G L Matters; L R Fitzpatrick; F Seibold; E E Sterchi; T Ahmad; D Lottaz; J S Bond
Journal:  Mucosal Immunol       Date:  2009-03-04       Impact factor: 7.313

Review 6.  The astacin family of metalloendopeptidases.

Authors:  J S Bond; R J Beynon
Journal:  Protein Sci       Date:  1995-07       Impact factor: 6.725

Review 7.  Meprin A metalloproteinase and its role in acute kidney injury.

Authors:  Gur P Kaushal; Randy S Haun; Christian Herzog; Sudhir V Shah
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-20

Review 8.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

9.  Critical amino acids in the active site of meprin metalloproteinases for substrate and peptide bond specificity.

Authors:  James P Villa; Greg P Bertenshaw; Judith S Bond
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

10.  Targeted disruption of the meprin beta gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles.

Authors:  Lourdes P Norman; Weiping Jiang; Xiaoli Han; Thomas L Saunders; Judith S Bond
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.